Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02534454 · ClinicalTrials.gov registry record · NA
TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence
A NA study, sponsored by The Mind Research Network.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT02534454 is a NA study that has completed, run by The Mind Research Network. The registered enrollment target is 86 participants.
The verdict
NCT02534454, a NA study, has completed, sponsored by The Mind Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
The purpose of the phase 1 translational pilot study proposed here is to gather preliminary data investigating the efficacy of transcranial direct current stimulation (TDCS) and cognitive retraining to enhance nicotine replacement therapy for smoking cessation. The recent use of TDCS over task relevant regions to alter behavior holds incredible promise for use in cognitive retraining intervention protocols. Previous studies of cognitive retraining have focused on implicit training techniques. This proposed study will attempt to enhance these implicit training techniques through the use of TDCS during implicit retraining in order to increase learning of avoidance-related action tendencies towards tobacco. The objective of this pilot study is to establish the feasibility and obtain preliminary data on the effectiveness of using brain stimulation with cognitive retraining to reduce cigarette smoking in individuals with nicotine addiction.
Interventions
- BEHAVIORAL Active Retraining
- BEHAVIORAL Sham Retraining
- DEVICE Active transcranial direct current stimulation (TDCS)
- DEVICE Sham transcranial direct current stimulation (TDCS)
- DRUG Nicotine Replacement Therapy (Habitrol)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2015-08-15 |
| Est. Completion | 2018-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02534454
The ClinicalTrials.gov registry entry for NCT02534454 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Mind Research Network, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Active Retraining is the first listed.
NCT02534454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02534454 about?
NCT02534454 is a clinical study titled "TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence". The purpose of the phase 1 translational pilot study proposed here is to gather preliminary data investigating the efficacy of transcranial direct current stimulation (TDCS) and cognitive retraining to enhance nicotine replacement therapy for smoking cessation. The recent use of TDCS over task relev...
What is the current status of trial NCT02534454?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2015-08-15. Estimated completion is 2018-03-31.
What interventions are being tested in trial NCT02534454?
The interventions under investigation include: Active Retraining (BEHAVIORAL), Sham Retraining (BEHAVIORAL), Active transcranial direct current stimulation (TDCS) (DEVICE), Sham transcranial direct current stimulation (TDCS) (DEVICE), Nicotine Replacement Therapy (Habitrol) (DRUG).
Who is sponsoring clinical trial NCT02534454?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.